Silk Road Medical (NASDAQ: SILK ) just reported results for the second quarter of 2024. Silk Road Medical reported earnings per share of -42 cents. This was below the analyst estimate for EPS of -38 cents. The company reported revenue of $51.24 million. This was 3.31% better than the analyst estimate for revenue of $49.60 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at [email protected]. More From InvestorPlace Legendary Investor Predicts: “Forget AI… THIS Technology Is the Future” The post SILK Stock Earnings: Silk Road Medical Misses EPS, Beats Revenue for Q2 2024 appeared first on InvestorPlace .

No summary available.

SUNNYVALE, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended June 30, 2024.

Boston Scientific Chairman and CEO Mike Mahoney joins ''Mad Money'' host Jim Cramer to talk quarterly results, the acquisition of Silk Road Medical and more.

https://www.investing.com/news/company-news/silk-road-medical-downgraded-to-hold-price-target-raised-to-2750-93CH-3521776

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Silk Road Medical, Inc. (NasdaqGS: SILK) to Boston Scientific Corporation (NYSE: BSX). Under the terms of the proposed transaction, shareholders of Silk Road will receive $27.50 in cash for each share of Silk Road that they own. KSF is seeking Jetzt den vollständigen Artikel lesen

NEW YORK, June 18, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Silk Road Medical, Inc. (NASDAQ: SILK)''s…

Boston Scientific has purchased Silk Road Medical, which makes products to help prevent strokes in patients with carotid artery disease.

U.S. stocks were slightly higher, with the Dow Jones index gaining around 0.1% on Tuesday. Shares of Patterson Companies, Inc . (NASDAQ: PDCO ) rose sharply during Tuesday''s session following quarterly results . Patterson Cos posted adjusted earnings of 82 cents per share on sales of $1.723 billion, according to data from Benzinga Pro. Patterson Companies shares climbed 9.7% to $25.06 on Tuesday. Here are some other big stocks recording gains in today’s session. Silk Road Medical, Inc (NASDAQ: SILK ) shares climbed 23.8% to $26.83 after the company entered a definitive deal to be acquired by Boston Scientific for $27.50 per share. La-Z-Boy Incorporated (NYSE: LZB ) surged 17.7% to $40.11. Karooooo Ltd . (NASDAQ: KARO ) rose 14.6% to $33.59 Chegg, Inc . (NYSE: CHGG ) gained 14.2% to $2.9811 after the company announced … Full story available on Benzinga.com

WASHINGTON (dpa-AFX) - Medical device company Boston Scientific Corp. (BSX) announced Tuesday it has entered into a definitive agreement to acquire smaller peer Silk Road Medical, Inc. (SILK) for …